Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 2
2019 2
2020 2
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study.
Katagiri S, Akahane D, Otsuki S, Suto A, Yamada A, Suguro T, Asano M, Yoshizawa S, Tanaka Y, Furuya N, Fujimoto H, Okabe S, Gotoh M, Ito Y, Gotoh A. Katagiri S, et al. Among authors: suguro t. Vaccines (Basel). 2022 Aug 27;10(9):1404. doi: 10.3390/vaccines10091404. Vaccines (Basel). 2022. PMID: 36146482 Free PMC article.
BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
Ito Y, Umezu T, Tadokoro K, Saito Y, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Tauchi T, Kawana C, Ohyashiki JH, Nakamura N, Ohyashiki K. Ito Y, et al. Among authors: suguro t. Leuk Lymphoma. 2019 May;60(5):1283-1288. doi: 10.1080/10428194.2018.1529310. Epub 2018 Nov 27. Leuk Lymphoma. 2019. PMID: 30480474
Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.
Saitoh Y, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Suguro T, Fujimoto H, Akahane D, Kobayashi-Kawana C, Ohyashiki JH, Ohyashiki K. Saitoh Y, et al. Among authors: suguro t. Oncol Lett. 2020 Mar;19(3):2053-2061. doi: 10.3892/ol.2020.11282. Epub 2020 Jan 9. Oncol Lett. 2020. PMID: 32194702 Free PMC article.
Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation.
Yamada A, Katagiri S, Moriyama M, Asano M, Suguro T, Yoshizawa S, Akahane D, Tanaka Y, Furuya N, Fujimoto H, Gotoh M, Aota Y, Nakamura N, Gotoh A. Yamada A, et al. Among authors: suguro t. J Infect Chemother. 2021 Jul;27(7):1076-1079. doi: 10.1016/j.jiac.2021.01.009. Epub 2021 Jan 29. J Infect Chemother. 2021. PMID: 33518401
Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
Yamada A, Araki Y, Tanaka Y, Otsuki S, Yamada A, Moriyama M, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Furuya N, Fujimoto H, Okabe S, Gotoh M, Suzuki K, Saito K, Gotoh A. Yamada A, et al. Among authors: suguro t. PLoS One. 2021 Jul 9;16(7):e0253025. doi: 10.1371/journal.pone.0253025. eCollection 2021. PLoS One. 2021. PMID: 34242226 Free PMC article.
Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Katagiri S, Umezu T, Azuma K, Kobayashi C, Akahane D, Suguro T, Furuya N, Fujimoto H, Nakamura N, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: suguro t. Bone Marrow Transplant. 2019 Jul;54(7):1148-1150. doi: 10.1038/s41409-019-0436-1. Epub 2019 Jan 22. Bone Marrow Transplant. 2019. PMID: 30670826 No abstract available.
13 results